Literature DB >> 24136618

22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.

Sara M Sarasua1, Alka Dwivedi1, Luigi Boccuto1, Chin-Fu Chen1, Julia L Sharp2, Jonathan D Rollins2, Julianne S Collins3, R Curtis Rogers1, Katy Phelan4, Barbara R DuPont1.   

Abstract

PURPOSE: Phelan-McDermid syndrome is a developmental disability syndrome with varying deletions of 22q13 and varying clinical severity. We tested the hypothesis that, in addition to loss of the telomeric gene SHANK3, specific genomic regions within 22q13 are associated with important clinical features.
METHODS: We used a customized oligo array comparative genomic hybridization of 22q12.3-terminus to obtain deletion breakpoints in a cohort of 70 patients with terminal 22q13 deletions. We used association and receiver operating characteristic statistical methods in a novel manner and also incorporated protein interaction networks to identify 22q13 genomic locations and genes associated with clinical features.
RESULTS: Specific genomic regions and candidate genes within 22q13.2q13.32 were associated with severity of speech/language delay, neonatal hypotonia, delayed age at walking, hair-pulling behaviors, male genital anomalies, dysplastic toenails, large/fleshy hands, macrocephaly, short and tall stature, facial asymmetry, and atypical reflexes. We also found regions suggestive of a negative association with autism spectrum disorders.
CONCLUSION: This work advances the field of research beyond the observation of a correlation between deletion size and phenotype and identifies candidate 22q13 loci, and in some cases specific genes, associated with singular clinical features observed in Phelan-McDermid syndrome. Our statistical approach may be useful in genotype-phenotype analyses for other microdeletion or microduplication syndromes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136618     DOI: 10.1038/gim.2013.144

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  42 in total

Review 1.  Induced pluripotent stem cells for modeling neurological disorders.

Authors:  Fabiele B Russo; Fernanda R Cugola; Isabella R Fernandes; Graciela C Pignatari; Patricia C B Beltrão-Braga
Journal:  World J Transplant       Date:  2015-12-24

2.  Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome).

Authors:  Gillian Reierson; Jon Bernstein; Wendy Froehlich-Santino; Alexander Urban; Carolin Purmann; Sean Berquist; Josh Jordan; Ruth O'Hara; Joachim Hallmayer
Journal:  J Psychiatr Res       Date:  2017-03-16       Impact factor: 4.791

3.  Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome.

Authors:  Gilles Droogmans; Ann Swillen; Griet Van Buggenhout
Journal:  Mol Syndromol       Date:  2019-11-05

Review 4.  A Clinical Review of Generalized Overgrowth Syndromes in the Era of Massively Parallel Sequencing.

Authors:  Benjamin Kamien; Anne Ronan; Gemma Poke; Ingrid Sinnerbrink; Gareth Baynam; Michelle Ward; William T Gibson; Tracy Dudding-Byth; Rodney J Scott
Journal:  Mol Syndromol       Date:  2018-01-25

Review 5.  Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Authors:  Jesse L Costales; Alexander Kolevzon
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 6.  Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.

Authors:  Hala Harony-Nicolas; Silvia De Rubeis; Alexander Kolevzon; Joseph D Buxbaum
Journal:  J Child Neurol       Date:  2015-09-08       Impact factor: 1.987

7.  Expression of SHANK3 in the Temporal Neocortex of Patients with Intractable Temporal Epilepsy and Epilepsy Rat Models.

Authors:  Yanke Zhang; Baobing Gao; Yan Xiong; Fangshuo Zheng; Xin Xu; Yong Yang; Yida Hu; Xuefeng Wang
Journal:  Cell Mol Neurobiol       Date:  2016-09-03       Impact factor: 5.046

8.  Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.

Authors:  Sara M Sarasua; Luigi Boccuto; Julia L Sharp; Alka Dwivedi; Chin-Fu Chen; Jonathan D Rollins; R Curtis Rogers; Katy Phelan; Barbara R DuPont
Journal:  Hum Genet       Date:  2014-01-31       Impact factor: 4.132

9.  Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis.

Authors:  Robert A Kozol; Holly N Cukier; Bing Zou; Vera Mayo; Silvia De Rubeis; Guiqing Cai; Anthony J Griswold; Patrice L Whitehead; Jonathan L Haines; John R Gilbert; Michael L Cuccaro; Eden R Martin; James D Baker; Joseph D Buxbaum; Margaret A Pericak-Vance; Julia E Dallman
Journal:  Hum Mol Genet       Date:  2015-04-16       Impact factor: 6.150

10.  SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex.

Authors:  Lorenza Culotta; Paolo Scalmani; Ersilia Vinci; Benedetta Terragni; Alessandro Sessa; Vania Broccoli; Massimo Mantegazza; Tobias Boeckers; Chiara Verpelli
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.